Speaker Profile
M.D., Ph.D., FACP, FACMGG, CEO and Director, Biological Dynamics
Biography
Dr. Paul Billings has devoted his life to studying and teaching medicine and genetics, while accelerating the use of a broad range of novel genomic technologies in clinical settings. As Chief Executive Officer, he leads strategy and growth for Biological Dynamics’ highly differentiated and proprietary platform for analyzing extracellular vesicles and exo-proteins to improve disease detection and management. Over decades in healthcare, he has established key business partnerships, driving adoption of innovative discoveries and commercial success. Dr. Billings has held academic appointments at Harvard, U.C. San Francisco, Stanford, and U.C. Berkeley; and served as board-certified internist and medical geneticist at leading medical centers. He has more than 225 biomedical citations and his published doctoral studies at Harvard were supervised by Dr. Baruj Benacerraf, who subsequently received the Nobel Prize in Medicine. He has served as Director or Advisor to numerous advisory boards and committees focused on medicine and genomic technologies.
Session Abstract – PMWC 2022 Silicon Valley
- Dismantling Barriers to Biomarker Testing Through Collaboration (PANEL)
Session Chair: Omar Perez, AstraZeneca
- Nikki Martin, LUNGevity
- Laura J. van ’t Veer, UCSF
- Jenn Higgins, Guardant Health
- Kat Kwiatkowski, Strata Oncology - Health Systems Perspective: Leveraging Real-world Evidence to Improve Patient Care (PANEL)
Session Chair: Anna Berry, Syapse
- Mary Walters, Aurora Health
- Haythem Y Ali, Henry Ford Health System - Comprehensive Profiling: Combination of Tissue and Plasma Biomarker Strategies
Session Chair: Maggie Rougier-Chapman, Personal Genome Diagnostics (PGDx)
- Cynthia Pointer, Genapsys
- Ravi Kolhe, Augusta University
- Stephen Miller, Blueprint Medicines - Immuno-oncology Biomarkers for Predicting Drug Efficacy
Session Chair: Ronnie Andrews, Oncocyte
- Paul Billings, Biological Dynamics
- Kat Kwiatkowski, Strata Oncology - Reimagining Oncology - Closing the Gaps between Science and Clinic (PANEL)
Session Chair: Christian Wolfrum, Siemens Healthineers
- Ben Gonzales, Biognosys AG
- Debanti Sengupta, Varian
- Rangarajan Sampath, Siemens Healthineers
- Isma Benattia, Amgen - Challenges to Implementing Precision Medicine in the Community Setting (PANEL)
Session Chair: Jerry Mitchell, Foundation Medicine
- Erika Brown, One Cancer Place
- Vivian Lee, Patient Advocate
- Kevin B. Knopf, Alameda Health System
- Christopher Woods, Sutter Health - Single Molecule Methylation Profiling of Circulating Tumor DNA
- Hanlee P. Ji, Stanford - Combined Utilization of Precision Medicine Technologies in Primary Clinics
- Gad Rennert, Carmel Medical Center - PMWC Showcase
- Paul Dempsey, Hawkeye Bio, Inc.
